Strides Pharma Science Limited (NSE:STAR)

Strides Pharma Science Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 25, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	83,421	61,675	72,114	25,858	31,121	75,754
Market Cap Growth	-4.93%	-14.47%	178.88%	-16.91%	-58.92%	162.55%
Enterprise Value	100,577	81,726	96,197	55,452	54,820	95,516
Last Close Price	905.05	666.20	307.19	111.72	135.23	328.51
PE Ratio	24.39	1.72	-	-	-	28.22
Forward PE	17.44	13.18	26.97	22.79	-	22.19
PS Ratio	1.80	1.35	1.85	0.70	1.01	2.29
PB Ratio	3.23	2.38	3.48	1.19	1.31	2.69
P/TBV Ratio	5.80	4.29	6.75	2.28	2.49	4.52
P/FCF Ratio	-	13.96	12.37	-	-	41.18
P/OCF Ratio	-	9.01	10.29	58.23	-	15.74
PEG Ratio	-	0.34	0.34	0.34	0.34	0.36
EV/Sales Ratio	2.17	1.79	2.47	1.50	1.79	2.88
EV/EBITDA Ratio	12.27	10.63	17.91	16.30	-	16.07
EV/EBIT Ratio	15.75	13.41	26.66	38.52	-	22.31
EV/FCF Ratio	-	18.50	16.50	-	-	51.92
Debt / Equity Ratio	0.73	0.73	1.22	1.39	1.27	0.83
Debt / EBITDA Ratio	2.30	2.37	4.39	8.10	-	3.81
Debt / FCF Ratio	-	4.25	4.32	-	-	12.77
Asset Turnover	-	0.77	0.62	0.54	0.44	0.50
Inventory Turnover	-	1.77	1.68	1.52	1.36	1.43
Quick Ratio	-	0.62	0.55	0.59	0.58	0.52
Current Ratio	-	1.20	1.03	1.09	0.99	1.03
Return on Equity (ROE)	-	17.58%	-6.78%	-10.13%	-18.25%	9.01%
Return on Assets (ROA)	-	6.41%	3.62%	1.32%	-2.12%	4.06%
Return on Capital (ROIC)	8.77%	8.41%	4.61%	1.70%	-2.81%	5.36%
Return on Capital Employed (ROCE)	-	17.60%	12.20%	3.90%	-	10.00%
Earnings Yield	4.09%	58.26%	-0.98%	-7.84%	-14.79%	3.54%
FCF Yield	-	7.17%	8.08%	-1.95%	-12.89%	2.43%
Dividend Yield	0.46%	0.60%	0.81%	1.34%	-	0.76%
Payout Ratio	-	0.64%	-	-	-	6.67%
Buyback Yield / Dilution	-0.60%	-1.12%	-1.02%	-0.37%	-0.04%	-0.14%
Total Shareholder Return	-0.14%	-0.52%	-0.21%	0.97%	-0.04%	0.62%

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.